Although candidate mediators (i.e., serum TMAO, IL-17, IL-10, and BDNF) were comparable in the acute phase of stroke, there were differences in biological functions such as the membrane transport and amino acid metabolism between the two groups. Here, IL10 is linked to stroke disorder.